Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Not Confirmed
Not Confirmed
01-02 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Industry Trade Show
Not Confirmed
01-02 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
27 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/27/3050542/0/en/LIXTE-Biotechnology-Provides-Update-On-Progress-with-Proprietary-Compound-LB-100-to-Treat-Ovarian-and-Colorectal-Cancer.html
10 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/10/3039731/0/en/New-Findings-Show-how-LIXTE-s-Lead-Clinical-Compound-LB-100-is-Metabolized-to-its-Active-Form.html
25 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/25/3032031/0/en/LIXTE-Adds-Northwestern-University-s-Lurie-Cancer-Center-as-Second-Site-in-Ongoing-Clinical-Trial-for-Ovarian-Clear-Cell-Cancer.html
13 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/13/3026049/0/en/LIXTE-Biotechnology-Announces-Closing-of-1-05-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
11 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/11/3024181/0/en/LIXTE-Biotechnology-Announces-1-05-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
10 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/10/3023823/0/en/LIXTE-Biotechnology-Submits-Request-for-Withdrawal-of-Form-S-1-Registration-Statement.html
ABOUT THIS PAGE